Will NVIDIA Stock Bounce Back?
After the wild market moves during February and March, investors…
Sell
50
NEUE Quote, Financials, Valuation and Earnings
Last price:
$6.66
Seasonality move
:
-9.86%
Day range:
$6.22 - $6.65
52-week range:
$3.79 - $7.66
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.06x
P/B ratio:
--
Volume:
8.3K
Avg. volume:
35K
1-year change:
9.74%
Market cap:
$57.3M
Revenue:
$936.7M
EPS (TTM):
-$22.63
NeueHealth Number of Institutional Trades
NeueHealth Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$581.6M
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$2.8M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NeueHealth Institutional Ownership
-
What Percentage Of NEUE Is Owned by Institutions?
-- of NEUE is owned by institutions.
-
How Many Institutions Own NEUE Shares?
NeueHealth stock is owned by 66 institutional shareholders at this time.
-
Have Institutions Been Buying NEUE Stock?
Yes, institutions have bought 52.9M shares of NEUE in the last quarter.
-
Have Institutions Been Selling NEUE Stock?
Yes, institutions have sold 119K shares of NEUE over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Energy Transfer a Good Dividend Stock to Buy Now?
Energy Transfer (NYSE:ET) offers an impressive yield, to say the…
Did the Market Bottom Already?
The past few weeks have been among the most volatile…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
47
RGC alert for Apr 15
Regencell Bioscience Holdings [RGC] is up 4.96% over the past day.
Sell
50
SLP alert for Apr 15
Simulations Plus [SLP] is down 0% over the past day.
Sell
46
ZLAB alert for Apr 15
Zai Lab [ZLAB] is down 1.65% over the past day.
